Eyes On Lips? Speechreading Skills and Facial Expression Discrimination in Children With and Without Impaired Hearing
Launched by UNIVERSITY OF OULU · May 2, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Eyes On Lips? Speechreading Skills and Facial Expression Discrimination in Children With and Without Impaired Hearing," is exploring how children understand spoken language by watching lip movements and facial expressions, especially in those with hearing loss. The researchers want to find out what factors help children do better at speechreading and how their eye movements relate to understanding emotions in spoken messages. They will also test a new speechreading app to see if it can help improve skills in children with hearing impairment.
To participate, children aged 8 to 11 years old can join if they are either normally hearing or have diagnosed bilateral hearing impairment. They must speak Finnish and have normal vision. This study will involve various tests, including speechreading tasks, and some children with hearing impairments will train using the speechreading app. The trial is currently recruiting participants, and it’s important to note that children with certain psychiatric or neurodevelopmental disorders may not be eligible. This research aims to help improve communication skills for both hearing and hearing-impaired children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Normally hearing children:
- • age 8-11 years
- • being born full-term (on 37. gestational week or later)
- • Finnish speaking (Finnish is the language the child's family uses at home, the child goes to a school where Finnish is used as the language of instruction)
- • normal hearing and vision
- • typically developing, mainstream education curriculum at school
- • for those tested remotely: computer available at home for remote testing
- Children with hearing impairment/loss:
- • age 8-11 years
- • diagnosed bilateral hearing impairment
- • being born full-term (on 37. gestational week or later)
- • Finnish speaking (Finnish is the language the child's family uses at home, the child goes to a school where Finnish is used as the language of instruction)
- • normal vision
- • (mainly) typically developing
- • for those tested remotely: computer available at home for remote testing
- Exclusion Criteria:
- • Normally hearing children: psychiatric and neurodevelopmental disorders, including ADHD (Attention Deficit and Hyperacitivity Disorder)
- • Children with hearing impairment/loss: psychiatric and neurodevelopmental disorders (excluding ADHD if medication helps the child to concentrate well during testing)
About University Of Oulu
The University of Oulu, located in Finland, is a leading research institution known for its commitment to advancing scientific knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the University of Oulu leverages its extensive academic expertise, state-of-the-art facilities, and collaborative networks to conduct rigorous and ethically sound clinical research. The university emphasizes interdisciplinary approaches and strives to translate research findings into practical applications that improve patient outcomes and contribute to public health. Through its clinical trials, the University of Oulu aims to foster advancements in medical science while adhering to the highest standards of integrity and compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oulu, , Finland
Patients applied
Trial Officials
Kerttu Huttunen, PhD
Principal Investigator
University of Oulu, Finland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported